BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3047990)

  • 1. [Effect of obsidan and labetalol on the course of myocardial infarction].
    Sirenko IuN; Mironova OV; Ivanova DK; Shkliar LV
    Vrach Delo; 1988 Jun; (6):20-3. PubMed ID: 3047990
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of labetalol and propranolol in patients who have had a myocardial infarct].
    Il'iash MG; Kravtsova LA; Babov KD; Shcherbak IaIu
    Vrach Delo; 1990 May; (5):26-8. PubMed ID: 2396387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure.
    Pinelli A; Trivulzio S; Tomasoni L; Brenna S; Bonacina E; Accinni R
    Eur J Pharm Sci; 2004 Nov; 23(3):277-85. PubMed ID: 15489129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of the effect of obsidan on the clinical picture of myocardial infarction at the early stage of the disease].
    Andriushchenko OM
    Klin Med (Mosk); 1989 Oct; 67(10):48-51. PubMed ID: 2615306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of labetalol on hemodynamics and oxygen consumption in patients in the early period of myocardial infarction].
    Gvatua NA; Mironova OV; Sirenko IuN; Tolstopiatov SM
    Kardiologiia; 1990 Apr; 30(4):30-3. PubMed ID: 2203928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
    Ivanova LK
    Vrach Delo; 1980 Oct; (10):15-8. PubMed ID: 6108019
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of obsidan on the content of catecholamines and renin in the blood in myocardial infarct].
    Simerzin VV
    Sov Med; 1988; (11):59-62. PubMed ID: 3070784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of obsidan in different hemodynamic variants of acute myocardial infarction].
    Netiazhenko VZ; Parkhomenko AN
    Vrach Delo; 1986 Jan; (1):12-5. PubMed ID: 3953032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
    Erina EV; Charyev KhE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):26-34. PubMed ID: 6139117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Propranolol (Inderal) in acute myocardial infarct].
    Nielsen BL; Jorgensen FS; Clausen J; Felsby M; Roin J; Strange B
    Ugeskr Laeger; 1967 May; 129(21):689-96. PubMed ID: 4877646
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of adrenergic beta receptor blockaders in myocardial infarct].
    Florkiewicz H; Rymar B; PrzegaliƄski J; Markiewicz M
    Pol Tyg Lek; 1980 Jun; 35(23):853-5. PubMed ID: 6997844
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of obsidan in patients with myocardial infarction].
    Dobrotvorskaia TE; Mustafaev FM; Arifullin ShS
    Kardiologiia; 1989 Jun; 29(6):71-5. PubMed ID: 2779085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmarketing comparison of labetalol and propranolol in hypertensive patients.
    Due DL; Giguere GC; Plachetka JR
    Clin Ther; 1986; 8(6):624-31. PubMed ID: 3791361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
    Hawkins CM; Richardson DW; Vokonas PS
    Circulation; 1983 Jun; 67(6 Pt 2):I94-7. PubMed ID: 6342843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nitrates and obsidan on myocardial infarction].
    Malinovskaia IE; Ivanova LK; Shkliar LV
    Vrach Delo; 1985 Jan; (1):56-9. PubMed ID: 3920832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.